Egypt Shrinks Subsidized Bread Loaf by 20 gms, Revises Cost of Flour

Egyptians buy bread from a street bakery in Cairo. (Reuters)
Egyptians buy bread from a street bakery in Cairo. (Reuters)
TT

Egypt Shrinks Subsidized Bread Loaf by 20 gms, Revises Cost of Flour

Egyptians buy bread from a street bakery in Cairo. (Reuters)
Egyptians buy bread from a street bakery in Cairo. (Reuters)

Egypt will shrink the size of its subsidized loaf of bread by 20 grams, a document seen by Reuters showed on Monday, allowing bakers to make more fixed price loaves from the standard 100-kg sack of flour.

Egypt, the world’s largest wheat importer, offers bread to more than 60 million people as part of a sprawling food subsidy program. Changes to food support are highly sensitive in Egypt, where a decision to cut bread subsidies led to deadly riots across the country in 1977.

The new weight of the loaf of bread will be 90 grams and each sack of flour shall yield 1,450 loaves effective Aug 18, the document showed.

A bakery owner in Cairo who chose to remain anonymous told Reuters that the change in the loaf would be noticeable to consumers.

“Due to many demands received by the ministry of supply from general bakers divisions across the country, we agreed to recalculate the cost of each sack of flour... (to account for) increases in gas and diesel fuel prices... and to add an insurance cost for bakery workers to be borne by the ministry,” Ahmed Kamal, the supply ministry’s spokesman, told Reuters.

The revised cost of the ministry’s standard sack of flour will now be 265 Egyptian pounds ($16.68) up from 213 Egyptian pounds ($13.40).

Subsidized bread would still cost 0.05 Egyptian pounds ($0.0031) and each individual would be allocated five loaves on the subsidy program, Kamal added.

“The ministry will tighten supervision on all bakeries to make sure the designated specifications, quality and weights necessary for the production of subsidized loaf (are followed, in addition to) the application of penalties and fines against violators.”



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.